Mounjaro weight loss injections in London: what the evidence actually shows

What the trial data says about Mounjaro as a weight-loss injection

The SURMOUNT-1 trial (published in the New England Journal of Medicine) randomised 2,539 adults with obesity and no type 2 diabetes to tirzepatide or placebo over 72 weeks. At the 15 mg dose, average weight loss reached around 20–21%, with some analyses reporting up to approximately 22.5%. These are meaningful numbers, but they describe a clinical-trial population following structured diet and activity support alongside the injection, context that matters when setting expectations.

NICE reviewed that body of evidence and, in December 2024, published Technology Appraisal TA1026, recommending tirzepatide for adults with a BMI of 35 or above and at least one weight-related health condition. Lower BMI thresholds apply for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds under that same guidance. For anyone who does not meet the NHS criteria or prefers not to wait, a private prescription route (through a regulated UK pharmacy) remains the legal alternative.

The SURMOUNT-5 trial, reported in 2025, went a step further: in a head-to-head comparison with semaglutide 2.4 mg, tirzepatide produced greater average weight reduction over 72 weeks. That result shapes how clinicians now think about which injection suits which patient, though individual response always varies. If you want to explore how tirzepatide works as a weight loss injection in its own right, our dedicated page covers the mechanism, dosing and what to expect in detail. You can also read more about how tirzepatide fits within the broader landscape of weight-loss injections like Mounjaro if you want a fuller comparison.

How the injection is used in practice, the questions London patients bring to our prescribers

A question our prescribers hear most weeks is whether living in London changes anything about how Mounjaro is used. It does not. The injection technique, schedule and monitoring expectations are the same wherever you are in the UK, because they follow the licensed prescribing information rather than local NHS guidelines.

Each KwikPen contains four weekly doses. You inject once a week into the abdomen, thigh or upper arm, rotating the site each time to avoid skin changes. The pen is pre-filled; no drawing up, no mixing. Pens are stored in the fridge between 2–8°C, and the patient information leaflet sets out the exact window for which a pen may be kept at room temperature, that detail is in the leaflet for a reason, and it is worth reading before you travel.

Needle changes matter more than people expect. Using a fresh needle for every injection reduces the risk of lipohypertophy, small lumps of fatty tissue that form when the same entry point is used repeatedly, and which can affect how well the medicine is absorbed. Our needle packs are available if you need them between orders. Injection-site rotation and correct technique are covered by your prescriber at the outset; if anything feels unclear mid-treatment, the aftercare team is available seven days a week.

For a closer look at the practical mechanics of the pen itself, the Mounjaro injection guide covers first-use setup, priming and site selection in detail.

Side effects, safety signals and when to seek help urgently

The side-effect profile of tirzepatide is well characterised across thousands of trial participants, and the NHS medicines page for tirzepatide is the clearest patient-level summary available. Most reported effects are gastrointestinal: nausea, loose stools, constipation, indigestion, burping. These are most pronounced at the start of each dose step and typically ease within one to two weeks as the body adjusts. Staying well hydrated and eating smaller, lower-fat meals helps most people get through the adjustment window.

Pancreatitis is an uncommon but serious risk. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis for this class of medicines. The symptom to act on immediately is severe, persistent stomach pain that radiates toward the back, with or without vomiting. That is a reason to call 111 or go to A&E, not to wait and see. Suspected side effects can be reported at yellowcard.mhra.gov.uk.

Women using oral contraceptives should be aware that tirzepatide slows gastric emptying in a way that can reduce pill absorption, particularly in the first four weeks of treatment and for four weeks after each dose increase. NHS guidance recommends adding a barrier method during those windows. This is a practical detail that is easy to miss in the excitement of starting treatment. Pregnancy, breastfeeding and trying to conceive are contraindications; Mounjaro is not licensed for anyone under 18.

Accessing Mounjaro privately in London through a regulated online pharmacy

There is no London-specific clinic or injection centre required. Mounjaro is a prescription-only medicine: the prescription comes from a clinician, not from geography. Through Mounjaro in London via a regulated online pharmacy such as nume, the process is a free online consultation, same-day clinical review by a GPhC-registered prescriber, and tracked next-working-day delivery by DPD in plain packaging, usually faster than attending a clinic in person.

Private pricing for tirzepatide varies by dose and provider. Following Eli Lilly's list price revision in September 2025, reported private monthly costs range from roughly £149 to £375 depending on dose and where you obtain your prescription. For a transparent view of what those costs typically include, the Mounjaro weight-loss injection cost page sets that out clearly. One honest point worth making: a lower headline price does not always mean a lower total cost once consultation fees, prescription charges and delivery are factored in.

The GPhC register is publicly searchable; any legitimate online pharmacy operating in the UK will have a registered premises number you can verify at pharmacyregulation.org. Red flags include sellers offering these medicines without a clinical assessment, social-media listings with prices well below market, and so-called discount codes, none of which belong in a safe supply chain for a prescription medicine.

If you want to understand how long it typically takes to see results once treatment begins, the guide on Mounjaro timelines covers what the evidence says week by week. When you are ready to talk it through with a clinician, speak to our prescribers through a free consultation, no commitment, no waiting list.